Gemox as First and Second Line Therapy in Unknown Primary Cancer

NCT00353145 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Unknown Primary Neoplasms

Interventions

DRUG: Gemcitabine (Gemox)
DRUG: Oxaliplatin
BEHAVIORAL: Questionnaire

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]